oral tirzepatide studies Safety and efficacy of as an add-on to single antihyperglycaemic medication in patients with type 2 diabetes in Japan (SURPASS J-combo): a multicentre, randomised, open-label, parallel-group, phase 3 trial Ozempic® (semaglutide) and Mounjaro™ (tirzepatide),

Whilst B12 (cobalamin) is essential for nerve function, red blood cell production, and DNA synthesis, there is no established direct link between B12 supplementation and joint pain in medical literature

Then, all participants were randomized to receive either Rytary or the immediate-release formulation for 13 weeks (totaling 22 weeks, or about five months, in the trial)

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved its use, and it is increasingly prescribed for glycaemic control

The total number of GLP-1-prescribing providers increased by 228% from July 2020 to May 2023

Using it solely for weight management may not be appropriate or effective

Return to moderate exercise typically possible